The Association Between Antibody Responses and Prolonged Viable Severe Acute Respiratory Syndrome Coronavirus 2 Shedding in Immunocompromised Patients: A Prospective Cohort Study
The Journal of Infectious Diseases · 2024
DOI: 10.1093/infdis/jiad579 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift The Journal of Infectious Diseases, 2024. Verfasst von So Yun Lim und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul. Hauptthemen laut MEDLINE: Virus Shedding, Immunocompromised Host, COVID-19, SARS-CoV-2. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 13 Literaturangaben. Gefördert von: Korea National Institute of Health, National Research Foundation of Korea, Ministry of Science and ICT, Republic of Korea.
Abstract (Originalsprache)
Immunocompromised patients with coronavirus disease 2019 were prospectively enrolled from March to November 2022 to understand the association between antibody responses and severe acute respiratory syndrome coronavirus 2 shedding. A total of 62 patients were analyzed, and the results indicated a faster decline in genomic and subgenomic viral RNA in patients with higher neutralizing and S1-specific immunoglobulin G (IgG) antibodies (both P < .001). Notably, high neutralizing antibody levels were associated with a significantly faster decrease in viable virus cultures (P = .04). Our observations suggest the role of neutralizing antibodies in prolonged virus shedding in immunocompromised patients, highlighting the potential benefits of enhancing their humoral immune response through vaccination or monoclonal antibody treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul.
- Division of Infectious Diseases, Department of Internal Medicine, National Medical Center, Seoul.
- National Institute of Infectious Diseases, Korea National Institute of Health, Korea Disease Control and Prevention Agency, Cheongju.
- Office for Infection Control, Asan Medical Center, Seoul, Republic of Korea.
ORCID-Profile: Sung-Han Kim
Förderung
- Korea National Institute of Health
- National Research Foundation of Korea
- Ministry of Science and ICT, Republic of Korea
Zitieren
APA
Lim, S. Y., Kim, J. W., Kim, J. Y., Kang, S. W., Jang, C. Y., Chang, E., Yang, J. S., Kim, K. C., Jang, H. C., Kim, D. S., Shin, Y., Lee, J. Y., & Kim, S. H. (2024). The Association Between Antibody Responses and Prolonged Viable Severe Acute Respiratory Syndrome Coronavirus 2 Shedding in Immunocompromised Patients: A Prospective Cohort Study. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiad579
Vancouver
Lim SY, Kim JW, Kim JY, Kang SW, Jang CY, Chang E, et al. The Association Between Antibody Responses and Prolonged Viable Severe Acute Respiratory Syndrome Coronavirus 2 Shedding in Immunocompromised Patients: A Prospective Cohort Study. The Journal of Infectious Diseases. 2024. doi:10.1093/infdis/jiad579
BibTeX
@article{Lim2024,
author = {Lim, So Yun and Kim, Jun-Won and Kim, Ji Yeun and Kang, Sung-Woon and Jang, Choi-Young and Chang, Euijin and Yang, Jeong-Sun and Kim, Kyung-Chang and Jang, Hee-Chang and Kim, Da Sol and Shin, Younmin and Lee, Joo-Yeon and Kim, Sung-Han},
title = {The Association Between Antibody Responses and Prolonged Viable Severe Acute Respiratory Syndrome Coronavirus 2 Shedding in Immunocompromised Patients: A Prospective Cohort Study},
journal = {The Journal of Infectious Diseases},
year = {2024},
doi = {10.1093/infdis/jiad579}
}
EUVIMED